Visceral fat is the fat found in the abdominal cavity and can pose serious health risks over time. One of the only ways to manage or even get rid of this type of fat in the body is through making dietary changes.
When it comes to losing visceral fat, Express reports that there is one big contributor to the accumulation of this kind of fat in the body; sugar. Sugar, especially refined sugars, is one of the worst enemies when it comes to shedding the visceral fat in the body. A lot of studies have further backed this up, finding that people who have added sugar in their diets tend to have more visceral fat compared to those who do not or at least take less sugar in their diets.
As to what makes sugar this dangerous when it comes to losing visceral fat, it all boils down to one compound in this ingredient: Fructose. A lot of fructose will turn into fat when it gets to the liver, adding up to the visceral fat a person may have in their abdomen.
So, with that in mind, the key to getting rid of visceral fat is to reducing or cutting out sugar intake in a diet. Along with reducing sugar intake, experts recommend increasing protein intake for overall weight loss and not just visceral fat. Eating more protein, as studies have shown, will suppress appetite and reduce the cravings a person may have in between. Lean meat, dairy, fish, nuts, and beans and legumes are good sources of protein.
Diet and exercise may be a big factor in losing visceral fat, but Express also reports that the amount of sleep a person gets also plays a part in losing weight. The recommended amount of sleep for a healthy lifestyle is seven to eight hours. A study spanning six years showed that people who got seven to eight hours of sleep every night gained less visceral fat by about 26 percent.
This also backs up the fact that less sleep means a bigger risk of developing visceral fat in the body. According to experts, those who sleep less than five hours tend to gain more weight over a span of five years.


Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Major Drugmakers Slash U.S. Prices and Sell Directly to Patients Amid Trump’s Push for Affordable Medicines
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 



